STOCK TITAN

Arteris (AIP) CFO sells 221,035 shares and exercises 213,021 options

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Arteris, Inc. VP and Chief Financial Officer Nicholas B. Hawkins reported an exercise-and-sell sequence in company stock. On May 15, 2026, he exercised stock options covering 213,021 shares of common stock at exercise prices of $0.56 and $9.28 per share.

On the same date, he sold 221,035 shares of common stock in open-market transactions at weighted average prices ranging from about $32.18 to $34.65 per share, according to the footnotes. After these trades, he continues to hold more than 100,000 shares directly.

Positive

  • None.

Negative

  • None.

Insights

CFO exercised low-priced options and sold shares in routine liquidity trades.

Arteris VP and CFO Nicholas B. Hawkins exercised options for 213,021 shares at relatively low strike prices of $0.56 and $9.28. He then sold 221,035 common shares in open-market transactions at weighted average prices in the low-to-mid $30 range.

This pattern reflects a typical exercise-and-sell sequence where derivative awards convert into common stock and cash. There is no indication of a Rule 10b5-1 trading plan in the provided data, and no remaining option positions are shown in the derivative summary, suggesting these particular option grants were fully exercised.

Insider Hawkins Nicholas B.
Role VP and Chief Financial Officer
Sold 221,035 shs ($7.38M)
Type Security Shares Price Value
Exercise Incentive Stock Option (right to buy) 197,396 $0.00 --
Exercise Non-Qualified Stock Option (right to buy) 15,625 $0.00 --
Exercise Common Stock 197,396 $0.56 $111K
Exercise Common Stock 15,625 $9.28 $145K
Sale Common Stock 52,928 $32.9749 $1.75M
Sale Common Stock 164,916 $33.5087 $5.53M
Sale Common Stock 3,191 $34.585 $110K
Holdings After Transaction: Incentive Stock Option (right to buy) — 0 shares (Direct, null); Non-Qualified Stock Option (right to buy) — 0 shares (Direct, null); Common Stock — 316,010 shares (Direct, null)
Footnotes (1)
  1. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.18 to $33.175 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $33.18 to $33.98 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.42 to $34.65 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Incentive stock options, 25% of the total shares vested on November 11, 2020 and the remainder vesting 1/48th monthly thereafter for three years. Non-qualified stock options, vesting in 16 equal quarterly installments of 1/16th each, beginning on April 1, 2025.
Shares sold 221,035 shares Common stock sold in open-market transactions on May 15, 2026
Shares from option exercises 213,021 shares Common shares acquired via option exercises on May 15, 2026
Sale price range (block 1) $32.18–$33.175/share Weighted-average sale price range noted in footnote F1
Sale price range (block 2) $33.18–$33.98/share Weighted-average sale price range noted in footnote F2
Sale price range (block 3) $34.42–$34.65/share Weighted-average sale price range noted in footnote F3
Incentive option strike price $0.56/share Exercise price for 197,396 incentive stock option shares
Non-qualified option strike price $9.28/share Exercise price for 15,625 non-qualified stock option shares
Remaining direct holdings (minimum) >100,000 shares Post-transaction direct ownership inferred from balances over 110,000 shares
Non-Qualified Stock Option (right to buy) financial
"security_title: "Non-Qualified Stock Option (right to buy)""
Incentive Stock Option (right to buy) financial
"security_title: "Incentive Stock Option (right to buy)""
weighted average sale price financial
"The price reported in Column 4 is a weighted average sale price."
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative exercise/conversion financial
"transaction_action: "derivative exercise/conversion""
Incentive stock options financial
"Incentive stock options, 25% of the total shares vested on November 11, 2020"
Incentive stock options are a type of employee stock option that gives eligible workers the right to buy company shares at a fixed price later on, often below future market value. They matter to investors because they align employee incentives with company performance, can dilute existing ownership when exercised, and create potential tax advantages for option holders if certain holding-time rules are met — think of them as a coupon to buy stock at today’s price with extra tax rules attached.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hawkins Nicholas B.

(Last)(First)(Middle)
C/O ARTERIS, INC.
900 E. HAMILTON AVE., SUITE 300

(Street)
CAMPBELL CALIFORNIA 95008

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
VP and Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/15/2026M197,396A$0.56316,010D
Common Stock05/15/2026M15,625A$9.28331,635D
Common Stock05/15/2026S52,928D$32.9749(1)278,707D
Common Stock05/15/2026S164,916D$33.5087(2)113,791D
Common Stock05/15/2026S3,191D$34.585(3)110,600D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Incentive Stock Option (right to buy)$0.5605/15/2026M197,396 (4)12/18/2029Common Stock197,396$0.000.00D
Non-Qualified Stock Option (right to buy)$9.2805/15/2026M15,625 (5)02/20/2035Common Stock15,625$0.000.00D
Explanation of Responses:
1. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.18 to $33.175 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $33.18 to $33.98 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.42 to $34.65 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. Incentive stock options, 25% of the total shares vested on November 11, 2020 and the remainder vesting 1/48th monthly thereafter for three years.
5. Non-qualified stock options, vesting in 16 equal quarterly installments of 1/16th each, beginning on April 1, 2025.
Remarks:
/s/ Paul Alpern, as Attorney-in-Fact for Hawkins Nicholas B.05/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Arteris (AIP) CFO Nicholas Hawkins report?

Nicholas B. Hawkins reported exercising stock options for 213,021 Arteris common shares and selling 221,035 shares in open-market trades on May 15, 2026. The filing shows both derivative exercises and subsequent stock sales in multiple weighted-average price ranges in the low-to-mid $30s.

How many Arteris (AIP) shares did the CFO sell and at what prices?

The CFO sold 221,035 Arteris common shares on May 15, 2026. Footnotes state these were multiple transactions at weighted-average prices, with ranges from $32.18–$33.175, $33.18–$33.98, and $34.42–$34.65 per share, all described as open-market sales.

What stock options did the Arteris (AIP) CFO exercise in this Form 4?

He exercised options for 197,396 shares at an exercise price of $0.56 and 15,625 shares at $9.28, both converting into Arteris common stock. These were incentive and non-qualified stock options that had vested over time under their stated vesting schedules.

Does the Arteris (AIP) CFO still hold shares after these transactions?

Yes. After the reported sales and option exercises, Nicholas B. Hawkins continues to hold more than 100,000 Arteris common shares directly. Individual transaction rows show post-transaction balances exceeding 110,000 shares, indicating a remaining equity stake following the May 15, 2026 trades.

Were the Arteris (AIP) CFO’s option exercises tied to specific vesting terms?

Yes. Footnotes explain that the incentive stock options vested 25% on November 11, 2020, with the remainder vesting monthly over three years, while the non-qualified stock options vest in 16 equal quarterly installments beginning April 1, 2025. These schedules governed when the options became exercisable.